Advertisement
UK markets close in 4 hours 42 minutes
  • FTSE 100

    8,105.64
    +26.78 (+0.33%)
     
  • FTSE 250

    19,817.17
    +215.19 (+1.10%)
     
  • AIM

    755.62
    +2.50 (+0.33%)
     
  • GBP/EUR

    1.1660
    +0.0003 (+0.03%)
     
  • GBP/USD

    1.2512
    +0.0001 (+0.01%)
     
  • Bitcoin GBP

    51,342.96
    +512.45 (+1.01%)
     
  • CMC Crypto 200

    1,388.53
    -8.00 (-0.57%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • CRUDE OIL

    83.98
    +0.41 (+0.49%)
     
  • GOLD FUTURES

    2,358.90
    +16.40 (+0.70%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,047.61
    +130.33 (+0.73%)
     
  • CAC 40

    8,030.38
    +13.73 (+0.17%)
     

Goldman Sachs cuts Reckitt to 'neutral' on share price outperformance

LONDON (ShareCast) - (ShareCast News) - Goldman Sachs (NYSE: GS-PB - news) has downgraded Reckitt Benckiser (Xetra: A0M1W6 - news) to 'neutral' from 'buy' and cut its price target to 6070p from 6390p, noting the 11% share price outperformance versus the consumer staples sector year-to-date. It said that since being added to the 'buy' list on 12 February 2014, the stock is up 31.8% versus the FTSE World Europe up 3.1%.

Goldman said it sees Reckitt as well positioned to take share in the over-the-counter market, both through bolt on M&A and share gains.

"We believe management can deliver the targeted cost savings through 'Project Supercharge' in full-year 2015 and beyond. However we believe this is reflected in the valuation and that the stock is now fairly valued." The bank downgraded its estimates by 6% for full-year 2015 and 7% for 2016 as it pushes out its M&A estimates following the lack of acquisitions this year to date.

At 1125 BST, Reckitt shares were down 3.2% at 5,928p.